The FDA has stated that there are no outstanding safety concerns with the device and granted Phase III initiation. Arthrosurface has been evaluating the safety and efficacy of
Ed Gallo, executive vice president of Concuity, said: “ClearContracts is a proven system that optimizes the revenue management cycle. We’re delighted to have Valley Baptist select ClearContracts for
Pillar SA is said to be the latest addition to Orthofix’s line of Pillar Peek spacer systems. The new spinal device is designed to be used in most
Cryoablation of cancer in the prostate will employ technology provided by Endocare, Irvine, California. Virgin dendritic cells (VDC2008) consist of each patient’s own immature dendritic cells obtained from
Most recently, Mr Beery has served as US Airways’s senior vice president and chief information officer, responsible for all IT business and operational systems and applications, process improvements,
Sunesis and SARcode have previously entered into a license agreement providing SARcode with an exclusive license to Sunesis’s LFA-1 technology to develop LFA-1 inhibitors. As part of the
This is a Phase II multi-center, parallel group, randomized study of palIfosfamide plus doxorubicin versus doxorubiCin in subjects with unresectable or metastatic soft-tissue sarcoma. Approximately 100 evaluable subjects
These new positions were created to support the company’s efforts to identify and pursue important growth opportunities for HP Acthar Gel. Mr O’Neill was senior director for biopharmaceuticals
The clearance is said to mark the company’s second 510(k) clearance and the first device on the market capable of treating an entire spectrum of disease found in
This open-label Phase IIa clinical trial is designed to evaluate an intravenous formulation of CK-1827452 in patients with stable heart failure undergoing clinically indicated coronary angiography in the
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.